REMEDEYE INC has a total of 15 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Brazil. Its main competitors in its focus markets pharmaceuticals and medical technology are THE POPULATION COUNCIL INC, NEWLENS LLC and INTEGRAL BIOSYSTEMS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | Chile | 1 | |
#6 | China | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 | |
#10 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Implantable devices |
# | Name | Total Patents |
---|---|---|
#1 | Rogosnitzky Moshe | 14 |
#2 | Moshe Rogosnitzky | 1 |
Publication | Filing date | Title |
---|---|---|
WO2017017540A1 | Therapeutic compositions containing dipyridamole, treatment packs and kits including such compositions, and methods for producing same | |
KR20150126021A | Compositions for use in treating eye disorders using dipyridamole | |
US2014275124A1 | Methods for treating eye disorders using dipyridamole | |
US2014213605A1 | Methods for treating eye disorders using opioid receptor antagonists |